side effects of taking too much semaglutide for diabetes and obesity treatment People Are Overdosing on Semaglutide

RELATED: 8 ways to save money on Ozempic How to save on Wegovy for weight loss Wegovy, DailyMed (2024) Ozempic, DailyMed (2025) Rybelsus, DailyMed (2024) Mounjaro, DailyMed (2025) Victoza, DailyMed (2024) Zepbound, DailyMed (2025) Saxenda, DailyMed (2024) Metformin, DailyMed (2020) RYBELSUS (semaglutide) savings and coverage tools for your patients, Novo Nordisk (2024) Chapter 6 Part drugs and formulary requirements, Medicare Prescription Drug Benefit Manual (2016) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) FDA approves Zepbound (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity, Lilly (2024) Declaratory order: Resolution of shortages of tirzepatide injection products (Mounjaro and Zepbound), Food and Drug Administration (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

In this episode, host Virgie Tovar sits down with Signe Darpinian, LMFT, CEDS, a licensed therapist and Certified Eating Disorder Specialist who works at the intersection of body image, mental health, and midlife change

In November 2025, the Trump Administration announced an upcoming demonstration project that will extend coverage for GLP-1s to people living with obesity and related complications starting later in 2026

Diabetologia 62 , 12511256 (2019)